A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.

Frazier TG, Fox KR, Smith JS, Laronga C, McSwain A, Paul D, Schultz M, Stilwill J, Teal C, Weisberg T, Vacchino JF, Sing AP, Cherepanov D, Hsiao W, Chang E, Broder MS

Open source

DOI: 10.3390/ph8010107
Published: 2015 Mar 17
Container: Pharmaceuticals (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ph8010107,
  title = {A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.},
  author = {Frazier TG and Fox KR and Smith JS and Laronga C and McSwain A and Paul D and Schultz M and Stilwill J and Teal C and Weisberg T and Vacchino JF and Sing AP and Cherepanov D and Hsiao W and Chang E and Broder MS},
  year = {2015},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph8010107},
  url = {https://doi.org/10.3390/ph8010107}
}

RIS

TY  - JOUR
TI  - A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
AU  - Frazier TG
AU  - Fox KR
AU  - Smith JS
AU  - Laronga C
AU  - McSwain A
AU  - Paul D
AU  - Schultz M
AU  - Stilwill J
AU  - Teal C
AU  - Weisberg T
AU  - Vacchino JF
AU  - Sing AP
AU  - Cherepanov D
AU  - Hsiao W
AU  - Chang E
AU  - Broder MS
PY  - 2015
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph8010107
UR  - https://doi.org/10.3390/ph8010107
ER  -

APA

TG, F., KR, F., JS, S., C, L., A, M., D, P., M, S., J, S., C, T., T, W., JF, V., AP, S., D, C., W, H., E, C., & MS, B. (2015). A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph8010107

Source records

pubmed · retrieved 2026-09-26T03:13:32.557Z